Product Information
MEXILETINE 200 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.2627 per EA under NDC 62756095601. Its NADAC has been published 231 times since Mar 23, 2022.
FDA first approved this application on Oct 1, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
200 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756095601
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
MEXILETINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214089FDA Approved
10/1/2021
TE Code
AB
On Market Since
11/29/2021
Pharmacological Classes
Price Statistics
The NADAC for MEXILETINE 200 MG CAPSULE has been published 231 times since Mar 23, 2022, and over the history we have for it it has declined 69.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2627 per EA |
|---|---|
| All-time high | $0.8561 (May 11, 2022) |
| All-time low | $0.2472 (May 21, 2025) |
| 52-week high | $0.3155 |
| 52-week low | $0.2570 |
| Median price | $0.3666 |
| Average price | $0.4369 |
| Largest weekly change | -32.6% (Nov 20, 2024) |
| Weeks tracked | 231 |
| Tracking since | Mar 23, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the mexiletine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MEXILETINE 200 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for MEXILETINE 200 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.2627 per EA (NDC 62756095601), effective Aug 19, 2026.
How has the price of MEXILETINE 200 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for MEXILETINE 200 MG CAPSULE has declined 69.2%. It has been tracked across 231 weekly CMS publications since Mar 23, 2022.
What are the highest and lowest recorded NADAC prices for MEXILETINE 200 MG CAPSULE?
Since Mar 23, 2022, the NADAC for MEXILETINE 200 MG CAPSULE has ranged from a low of $0.2472 (May 21, 2025) to a high of $0.8561 (May 11, 2022), with a median of $0.3666 per EA.
Are there cheaper alternatives to MEXILETINE 200 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of MEXILETINE 200 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MEXILETINE 200 MG CAPSULE?
MEXILETINE 200 MG CAPSULE (NDC 62756095601) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.